Advancements in the US Breast Matrices Market continue to unfold as companies work to build the knowledge base about recently introduced biosynthetic breast matrices to help surgeons optimize long-term outcomes and improve the standard of care. At this year’s Plastic Surgery The Meeting (PSTM 24), held September 26-29 in San Diego, California, SmartTRAK identified several research and product trends that could potentially impact the US Breast Matrices Market, particularly in biosynthetic breast matrices. This includes a growing interest in new biosynthetic materials, focusing on long-term aesthetic results, expanding into new indications and using biosynthetics in breast reconstruction.
Among the topics discussed in this informative perspective article are:
Click the button below to download and read the complete "PSTM 2024 Annual Meeting Highlights" perspective article by Doug Devens. SmartTRAK Sr. Product Director/Sr. Analyst - Wound.
SmartTRAK is the Medtech industry’s only global Insights-as-a-Service solution for the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets. SmartTRAK’s propriety methodology turns disparate data from hundreds of sources into powerful insights customers can rely on as the trusted source for strategic decision-making. The SmartTRAK enterprise platform includes rich daily updates, comprehensive market coverage and simple-to-use tools and dashboards for market, product and financial analysis. Customers leveraging the SmartTRAK platform also have direct access to market experts for inquiries and advisory services. If you would like a demo of what SmartTRAK has to offer and see how we can help increase proficiency, improve productivity and reduce costs for your company, just click here.